{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T19:53:38Z","timestamp":1793044418593,"version":"4.5.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.urolonc.2023.12.008","type":"journal-article","created":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T08:36:06Z","timestamp":1705998966000},"page":"69.e11-69.e16","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Impact of variant histology on upstaging and survival in patients with nonmuscle invasive bladder cancer undergoing radical cystectomy"],"prefix":"10.1016","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1302-308X","authenticated-orcid":false,"given":"J.","family":"McFadden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Tachibana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Adra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Cary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Koch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Kaimakliotis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.A.","family":"Masterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.R.","family":"Rice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 2","key":"10.1016\/j.urolonc.2023.12.008_bib0001","doi-asserted-by":"crossref","first-page":"S96","DOI":"10.1038\/modpathol.2009.26","article-title":"Histological variants of urothelial carcinoma: diagnostic, therapeutic and prognostic implications","volume":"22","author":"Amin","year":"2009","journal-title":"Mod Pathol"},{"issue":"8","key":"10.1016\/j.urolonc.2023.12.008_bib0002","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1016\/j.urolonc.2012.04.009","article-title":"Variant (divergent) histologic differentiation in urothelial carcinoma is under-recognized in community practice: impact of mandatory central pathology review at a large referral hospital","volume":"31","author":"Shah","year":"2013","journal-title":"Urol Oncol"},{"issue":"6","key":"10.1016\/j.urolonc.2023.12.008_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2022.01.008","article-title":"Variant histologies in bladder cancer: does the centre have an impact in detection accuracy?","volume":"40","author":"Cimadamore","year":"2022","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2023.12.008_bib0004","series-title":"WHO classification of tumours editorial board. Urinary and male genital tumours","article-title":"Tumours of the urinary tract: invasive urothelial carcinoma","volume":"vol. 8","author":"Netto","year":"2022"},{"issue":"6","key":"10.1016\/j.urolonc.2023.12.008_bib0005","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.urolonc.2016.12.006","article-title":"Incidence and effect of variant histology on oncological outcomes in patients with bladder cancer treated with radical cystectomy","volume":"35","author":"Moschini","year":"2017","journal-title":"Urol Oncol"},{"issue":"6","key":"10.1016\/j.urolonc.2023.12.008_bib0006","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1159\/000514759","article-title":"Non-muscle invasive bladder cancer with variant histology: biological features and clinical implications","volume":"99","author":"Sanguedolce","year":"2021","journal-title":"Oncology"},{"issue":"6","key":"10.1016\/j.urolonc.2023.12.008_bib0007","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1097\/JU.0000000000001305","article-title":"A systematic review and meta-analysis of variant histology in urothelial carcinoma of the bladder treated with radical cystectomy","volume":"204","author":"Mori","year":"2020","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.urolonc.2023.12.008_bib0008","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.euf.2019.09.003","article-title":"What is the significance of variant histology in urothelial carcinoma?","volume":"6","author":"Lobo","year":"2020","journal-title":"Eur Urol Focus"},{"issue":"1","key":"10.1016\/j.urolonc.2023.12.008_bib0009","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.urology.2007.03.033","article-title":"Urothelial carcinoma with divergent histologic differentiation (mixed histologic features) predicts the presence of locally advanced bladder cancer when detected at transurethral resection","volume":"70","author":"Wasco","year":"2007","journal-title":"Urology"},{"issue":"1","key":"10.1016\/j.urolonc.2023.12.008_bib0010","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.juro.2009.02.116","article-title":"Multiple adverse histological features increase the odds of under staging T1 bladder cancer","volume":"182","author":"Weizer","year":"2009","journal-title":"J Urol"},{"issue":"3 Pt 1","key":"10.1016\/j.urolonc.2023.12.008_bib0011","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0022-5347(05)00423-4","article-title":"The case for early cystectomy in the treatment of nonmuscle invasive micropapillary bladder carcinoma","volume":"175","author":"Kamat","year":"2006","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.urolonc.2023.12.008_bib0012","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.juro.2016.06.049","article-title":"Diagnosis and treatment of non-muscle invasive bladder cancer: AUA\/SUO guideline","volume":"196","author":"Chang","year":"2016","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.urolonc.2023.12.008_bib0013","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.eururo.2021.08.010","article-title":"European Association of Urology guidelines on non-muscle-invasive bladder cancer (Ta, T1, and carcinoma in situ)","volume":"81","author":"Babjuk","year":"2022","journal-title":"Eur Urol"},{"issue":"2","key":"10.1016\/j.urolonc.2023.12.008_bib0014","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.4081\/rt.2011.e22","article-title":"Is radical cystectomy mandatory in every patient with variant histology of bladder cancer","volume":"3","author":"Shapur","year":"2011","journal-title":"Rare Tumors"},{"issue":"6","key":"10.1016\/j.urolonc.2023.12.008_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2022.02.004","article-title":"Histological variants of non-muscle invasive bladder cancer: survival outcomes of radical cystectomy vs. bladder preservation therapy","volume":"40","author":"Dursun","year":"2022","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2023.12.008_bib0016","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3389\/fonc.2016.00043","article-title":"The response of variant histology bladder cancer to intravesical immunotherapy compared to conventional cancer","volume":"6","author":"Gofrit","year":"2016","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.urolonc.2023.12.008_bib0017","doi-asserted-by":"crossref","first-page":"15268","DOI":"10.1038\/s41598-019-51889-0","article-title":"BCG instillation versus radical cystectomy for high-risk NMIBC with squamous\/glandular histologic variants","volume":"9","author":"Suh","year":"2019","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.urolonc.2023.12.008_bib0018","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/his.13752","article-title":"Variants and new entities of bladder cancer","volume":"74","author":"Lopez-Beltran","year":"2019","journal-title":"Histopathology"},{"issue":"2","key":"10.1016\/j.urolonc.2023.12.008_bib0019","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.urolonc.2012.08.017","article-title":"Does presence of squamous and glandular differentiation in urothelial carcinoma of the bladder at cystectomy portend poor prognosis? An intensive case-control analysis","volume":"32","author":"Mitra","year":"2014","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2023.12.008_bib0020","article-title":"Clinical outcomes of patients with t1 nested variant of urothelial carcinoma compared to pure urothelial carcinoma of the bladder","author":"Mally","year":"2017","journal-title":"Clin Genitourin Cancer"},{"issue":"4","key":"10.1016\/j.urolonc.2023.12.008_bib0021","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3233\/BLC-160066","article-title":"Micropapillary bladder cancer: insights from the national cancer database","volume":"2","author":"Sui","year":"2016","journal-title":"Bladder Cancer"},{"issue":"4","key":"10.1016\/j.urolonc.2023.12.008_bib0022","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.eururo.2018.11.052","article-title":"Micropapillary urothelial carcinoma of the bladder: a systematic review and meta-analysis of disease characteristics and treatment outcomes","volume":"75","author":"Abufaraj","year":"2019","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.urolonc.2023.12.008_bib0023","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s12935-020-01626-9","article-title":"Sarcomatoid variant urothelial carcinoma of the bladder: a systematic review and meta-analysis of the clinicopathological features and survival outcomes","volume":"20","author":"Gu","year":"2020","journal-title":"Cancer Cell Int"},{"issue":"5","key":"10.1016\/j.urolonc.2023.12.008_bib0024","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.urology.2013.12.035","article-title":"Plasmacytoid bladder cancer: variant histology with aggressive behavior and a new mode of invasion along fascial planes","volume":"83","author":"Kaimakliotis","year":"2014","journal-title":"Urology"},{"issue":"4","key":"10.1016\/j.urolonc.2023.12.008_bib0025","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.eururo.2017.03.030","article-title":"Impact of molecular subtypes in muscle-invasive bladder cancer on predicting response and survival after neoadjuvant chemotherapy","volume":"72","author":"Seiler","year":"2017","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.urolonc.2023.12.008_bib0026","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.euo.2019.06.012","article-title":"Does variant histology change management of non-muscle-invasive bladder cancer?","volume":"4","author":"Burger","year":"2021","journal-title":"Eur Urol Oncol"},{"issue":"5","key":"10.1016\/j.urolonc.2023.12.008_bib0027","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1097\/MOU.0000000000000086","article-title":"Impact of histological variants on the outcomes of nonmuscle invasive bladder cancer after transurethral resection","volume":"24","author":"Seisen","year":"2014","journal-title":"Curr Opin Urol"},{"issue":"5","key":"10.1016\/j.urolonc.2023.12.008_bib0028","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s00428-021-03264-6","article-title":"T1 bladder carcinoma with variant histology: pathological features and clinical significance","volume":"480","author":"Lopez-Beltran","year":"2022","journal-title":"Virchows Arch"},{"issue":"1","key":"10.1016\/j.urolonc.2023.12.008_bib0029","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.clgc.2020.06.004","article-title":"Role of neoadjuvant chemotherapy in squamous variant histology in urothelial bladder cancer: does presence and percentage matter?","volume":"19","author":"Speir","year":"2021","journal-title":"Clin Genitourin Cancer"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143923004878?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143923004878?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:28:23Z","timestamp":1761042503000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143923004878"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S1078143923004878"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2023.12.008","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of variant histology on upstaging and survival in patients with nonmuscle invasive bladder cancer undergoing radical cystectomy","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2023.12.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}